help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Toyokuni, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Toyokuni, S.
(American Journal of Pathology. 2000;156:2149-2157.)
© 2000 American Society for Investigative Pathology


Regular Articles

Expression of Stress-Response and Cell Proliferation Genes in Renal Cell Carcinoma Induced by Oxidative Stress

Tomoyuki Tanaka, Shohei Kondo, Yoko Iwasa, Hiroshi Hiai and Shinya Toyokuni

From the Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Ferric nitrilotriacetate induces oxidative damage in renal proximal tubules that ultimately leads to a high incidence of renal cell carcinoma (RCC) in rats. In search of genes specifically involved in oxystress-induced carcinogenesis, we have applied a modified fluorescent differential display technique to the tumors and an established cell line as well as their non-neoplastic counterparts. We screened approximately 84,000 products. Reverse Northern blotting confirmed differential expression of 20 transcripts, which showed either significant increase, decrease or lack of expression in the RCCs. Five cDNA clones encoded novel products of unknown function. Fifteen cDNA clones were identified by homology search, which included annexin II, Y-box binding protein, ribosomal proteins, heat shock proteins, DNA polymerase, nonmuscle caldesmon (increased); protein tyrosine phosphatase (decreased); selenoprotein P, stromal cell-derived factor 1, intestinal trefoil protein, nicotinamide adenine dinucleotide, reduced form (NADH) dehydrogenase, and insulin-like growth factor binding protein 7 (deleted). Most of the identified genes were associated with stress-response or cellular proliferation. These results suggest that multiple, interactive genetic pathways are involved in carcinogenesis induced by oxidative stress.



    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
A role of oxidative stress in carcinogenesis has been widely accepted.1,2 However, the mechanisms involved are still largely unknown. To elucidate the detailed genetic processes, we have been working on a rat model in which involvement of reactive oxygen species (ROS) are highly likely; an iron chelate, ferric nitrilotriacetate (Fe-NTA), induces renal proximal tubular degeneration, a consequence of oxidative injury after Fenton-like reaction, that ultimately leads to a high incidence of renal cell carcinoma (RCC).3-6 We have thus far demonstrated in the target organ of this model increased levels of lipid peroxidation products (thiobarbituric acid-reactive substances, various aldehydes including malondialdehyde and 4-hydroxy-2-nonenal),7,8 aldehyde-modified proteins,9,10 and a variety of oxidatively modified DNA bases,11 as well as thymine-tyrosine DNA-protein cross-links.12 A load of oxidative stress on the renal tubular cells is further thought to continue for the whole life in the rats that received repeated injecting of Fe-NTA, chiefly because of heavy iron deposition.5,6 These data strongly suggest the involvement of ROS in the initiation, promotion and progression processes of carcinogenesis. In a previous report, we found by a genetic approach frequent loss of heterozygosity (LOH) on chromosome 5 and 8 in Fe-NTA-induced rat RCCs. This led to a finding that p15INK4B and p16INK4A tumor suppressor genes are two of the major targets, which were either deleted or methylated in the 5' CpG island region in approximately half of the cases.13

In the present study, to identify and isolate differentially expressed genes during oxystress-induced renal carcinogenesis, we have developed and used modified fluorescent differential display (FDD) technique. We identified 15 genes that revealed either significant increase, decrease, or lack of expression, and also found five novel transcripts. Most of the identified genes were associated either with stress-response or cellular proliferation.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Tissue Samples and Cell Lines

RCCs were induced in F1 hybrid rats between Wistar strain (Shizuoka Laboratory Animal Center, Shizuoka, Japan) and Long-Evans strain (originally outbred from Ben May Laboratory for Cancer Research, University of Chicago, Chicago, IL) by administrating Fe-NTA as previously described.13-15 RCCs or nontumorous renal tissues were carefully dissected with razor blades and kept frozen at -80°C until use. FRCC001 cell line was established from a Fe-NTA-induced renal cell carcinoma (F1 hybrid rat, No. 10-21-4, grade-2, granular cell subtype, solid structure, INF-ß with lung metastasis)15 using a procedure previously described,16 and were grown in Dulbecco’s modified Eagle’s medium (GIBCO, Grand Island, NY) supplemented with 10% fetal bovine serum (HyClone Laboratories, Logan, UT) and antibiotics/antimycotics (GIBCO; penicillin G 100 U/ml; streptomycin sulfate 100 µg/ml; amphotericin B 0.25 µg/ml). This cell line formed typical epithelial monolayers on plastic, revealed anchorage-independent growth after confluence, and proliferated well in the subcutis of nude mice with no evidence of metastasis.

RNA Isolation and Northern Blotting

Total RNA was isolated from each frozen tissue or cells by means of a modified acid guanidinium/phenol/chloroform method (Isogen, Nippon Gene, Tokyo). Poly(A)-rich RNA was isolated by oligo(dT)-latex beads (Nippon Roche, Tokyo). For Northern blot analysis, poly(A)-rich RNA sample (2 µg) was separated on 1% agarose gel containing formaldehyde and transferred onto nylon membrane as previously reported.17 We used as probes the isolated cDNA clones by FDD, which were labeled with [{alpha}-32P]dCTP by Megaprime DNA labeling system (Amersham Pharmacia Biotech, Tokyo). Autoradiography was performed using an imaging plate (Fuji Film, Tokyo) and the visualization and quantitation were done with BAS2000 (Fuji Film). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene was used as a standard for quantitation.

Differential Display

Total RNA was treated with RNase-free DNase using a Message clean kit (GenHunter Corp., Brookline, MA). Random oligonucleotide primers (20–22 mer) synthesized were used as arbitrary primers. Anchor primers were synthesized as follows: 5'-CCCGGATCC (dT)15N-3' (where N is C, G, or A; this primer was designed to include BamHI site) and were labeled with rhodamine at the 5'-end of the oligonucleotides. A 500-ng aliquot of total RNA was reverse transcribed in 1x reverse transcriptase buffer (10 mmol/L Tris-HCl, pH 8.3, 50 mmol/L KCl) with 5 mmol/L MgCl2, 1 mmol/L deoxynucleotide phosphates (dNTP), 20 U RNase inhibitor, and 50 pmol of each anchor primer. Each sample was incubated for 10 minutes at 70°C and then cooled on ice. This was followed by addition of 1.5 mU avian myeloblastosis virus reverse transcriptase (Takara Bio, Shiga, Japan) in a total volume of 20 µl, which was incubated at 30°C for 10 minutes and at 55°C for 30 minutes. Reverse transcriptase was inactivated by incubation at 95°C for 5 minutes. For each PCR reaction, 2 µl of cDNA was dissolved in a volume of 20 µl in PCR buffer (10 mmol/L Tris-HCl, pH 8.3, 50 mmol/L KCl, 1.5 mmol/L MgCl2) in the presence of 0.1 mmol/L dNTP, 10 pmol of arbitrary primer, 5 pmol of anchor primer, and 0.5 U Taq polymerase (Takara Bio). PCR conditions were 94°C for 5 minutes, 37°C for 5 minutes, 72°C for 5 minutes, which was followed by 34 cycles of 94°C for 30 seconds, 37°C for 2 minutes, and 72°C for 1 minute. A final extension reaction was carried out at 72°C for 5 minutes. Five microliters of each PCR product was analyzed by electrophoresis in 7 mol/L urea/4% polyacrylamide gel at 40 W constant power for 2 to 3 hours. Gels were visualized with a fluorescence image analyzer (FMBIO-100, Takara Bio). The fragments showing differential expression were excised from the gel with razor blade, extracted by heating in water, and then reamplified by PCR using the corresponding primer pair.

Cloning and cDNA Sequencing of Fragments Obtained by Differential Display

An aliquot of reamplified cDNA was checked for a single band by urea/polyacrylamide gel electrophoresis. In case of multiple bands, the procedures were repeated until single band was obtained. Then the rest of the product was digested with BamHI (Takara Bio) to remove rhodamine labeling as well as to obtain cohesive end, and was loaded to 1% agarose gel. The band was carefully excised and extracted from the gel by the use of QIAEX II gel extraction kit (QIAGEN, Tokyo). The product was finally cloned into the pBluescript II SK(+) vector (Stratagene, La Jolla, CA) after treating the vector first with HincII digestion (Takara Bio), then with terminal deoxynucleotidyl transferase (Takara Bio) for adding dT at the blunt end and finally with BamHI. The plasmid DNAs were sequenced with the AmpliTaq Cycle Sequence kit (Perkin Elmer, Foster City, CA) according to the manufacturer’s protocol using an ABI PRISM 377 DNA sequencer. The homology search was performed with Genomenet World Wide Web server (http://www.genome.ad.jp).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Differential Display and Reverse Northern Blotting

To isolate genes differentially expressed in oxystress-induced rat RCCs, we have used five samples as a set: cortical portion of normal kidney (1-year-old F1), cortical non-neoplastic portion of Fe-NTA-treated kidney (1-year-old), two independent RCCs (a grade 2 RCC with lung metastasis and a grade 1 RCC with no metastasis), and a RCC cell line (FRCC001) established from Fe-NTA-induced RCC of grade 2. Total RNA was isolated from each sample and was reverse transcribed to cDNA. Using three kinds of anchor primers in combination with 280 arbitrary primers, an average of approximately 100 cDNA transcripts was amplified and displayed in each lane of the gel. Thus, in total, approximately 84,000 clones were compared on display for the set of samples.

Our strategy was to select only clones that showed different expression pattern between the former two samples (normal control and non-neoplastic after Fe-NTA administration) and the latter three samples (two RCC tissues and one RCC cell line) to avoid false positive clones. We found a total of 290 clones to be differentially expressed. Examples of representative FDD runs are shown in Figure 1 . Each band was carefully excised from the gel by a razor blade, purified, and reamplified. Among these, 142 clones were successfully subcloned and sequenced. Using each cDNA clone as a probe, 72 selected clones (more than fivefold increase or decrease by FDD) were subjected to reverse Northern blotting for which a different set of samples (normal renal cortex of a 1-year-old male F1 rat, renal cortex of a 12-week-old male Wistar rat after 6 weeks of repeated Fe-NTA administration, two pairs of RCCs and their nontumorous counterparts: a grade 1 RCC with no metastasis and a grade 3 RCC with lung metastasis and peritoneal invasion) were prepared (Figure 2) . Finally, 20 cDNA clones were confirmed to be differentially expressed (Figure 1, A–F , and Figure 2, A–F ); the remaining cDNA clones either showed no signal or difference in expression by Northern blots or exhibited no difference between RCCs and its non-neoplastic counterparts. These were interpreted as false positive and excluded from the present study.



View larger version (101K):
[in this window]
[in a new window]
 
Figure 1. Fluorescent differential display of Fe-NTA-induced RCCs and non-neoplastic renal tissues. Total RNA was isolated from normal cortical kidney (lane 1), non-neoplastic cortical kidney after Fe-NTA treatment (lane 2), Fe-NTA-induced RCCs (grade 2 RCC, lane 3; grade 1 RCC, lane 5), FRCC001 cell line established from a grade 2 RCC of lane 3 (lane 4), reverse transcribed and followed by PCR in the presence of rhodamine-labeled anchor primer and each arbitrary primer. The PCR fragments were displayed on 7 mol/L urea-4% polyacrylamide gels and visualized as detailed in Materials and Methods and in Results. Fragments of clone 29 (A), clone 61 (B), clone 91 (C), clone 126 (D), clone 230 (E), and clone 256 (F) are indicated by arrows. Transcript clones are summarized in Table 1 .

 


View larger version (45K):
[in this window]
[in a new window]
 
Figure 2. Northern blot analysis of identified and novel transcripts in neoplastic and non-neoplastic rat renal tissues. Two µg of poly (A)-rich RNA was isolated from rat tissue (lane 1, normal cortical kidney; lane 2, non-neoplastic cortical kidney after 6 weeks of repeated Fe-NTA treatment; lanes 3 and 5, non-tumorous part of the cortical kidney; lanes 4 and 6, Fe-NTA-induced RCCs of grades 1 and 3, respectively. Lanes 3 and 4, and lanes 5 and 6 are paired samples) and subjected to Northern blot analysis as detailed in materials and methods. Subcloned cDNA fragments (A, clone 29; B, clone 61; C, clone 91; D, clone 126; E, clone 230; F, clone 256) summarized in Table 1 were used as probes, respectively. Size of each band was determined by relative migration of 18S and 28S ribosomal RNA. GAPDH was used as loading controls. Transcript clones are summarized in Table 1 .

 
Unidentified Genes Differentially Expressed in the Fe-NTA-Induced RCCs

Sequence analyses revealed clones 28, 29, 256, 418, and 435 as novel gene fragments (Figure 3) . Clone 28 was overexpressed, whereas the others were deleted in expression in the Fe-NTA-induced RCCs. Homology search through GenBank and EMBL databases using BLAST programs revealed no significant homology with any published genes in the five clones. Each clone showed single band by Northern blots; the sizes were 2.6 kb in clone 28, 2.8 kb in clone 29, 1.6 kb in clone 256, 2.0 kb in clone 418, and 2.4 kb in clone 435. All of the fragments were flanked by DNA sequence of the corresponding oligo(dT) primer and arbitrary primer used for FDD and further revealed polyadenylation signal sequence (AAUAAA) upstream of the putative polyA tail.



View larger version (63K):
[in this window]
[in a new window]
 
Figure 3. Nucleotide sequence of five differentially expressed novel transcripts. Five clones reveals no homology to the GenBank/EMBL data base. Flanking sequences of primer sets are underlined. The polyadenylation signal sequence is in bold letters.

 
Identified Genes Differentially Expressed in the Fe-NTA-Induced RCCs

In the present FDD study, we have identified 15 genes as differentially expressed. Increased in the Fe-NTA-induced RCCs were homologues of Y-box binding protein, heat shock protein (HSP) 86, DNA polymerase catalytic subunit {alpha} and glycoproteins of 96 kd (gp96); ribosomal proteins (RPs) S13, S15 and L19; non-muscle caldesmon and annexin II (calpactin I heavy chain) as shown in Table 1 . We estimated the increase of expression in the RCCs as 7.8- to 14.3-fold (1.3- to 2.3-fold) for the homologue of Y-box binding protein, 1.7- to 1.8-fold (0.93- to 1.4-fold) for the homologue of HSP 86, 2.8- to 4.0-fold (0.8- to 1.5-fold) for RP S15, 3.1- to 3.3-fold (1.4- to 2.7-fold) for RP S13, 1.7- to 2.4-fold (1.1- to 1.3-fold) for RP L19, and 2.3- to 2.6-fold (1.6- to 1.8-fold) for the homologue of gp96 as compared with a control sample of normal age-adjusted kidney. (Data for kidney after 6 weeks of repeated Fe-NTA administration are shown in parentheses.) Expression of the homologue of DNA polymerase catalytic subunit {alpha}, nonmuscle caldesmon (Figure 2C) and annexin II in the samples of non-neoplastic kidneys was under the detection limit of Northern blot.


View this table:
[in this window]
[in a new window]
 
Table 1. Genes Differentially Expressed in Fe-NTA-Induced Renal Cell Carcinoma of Rats

 
Expression of the homologue of protein tyrosine phosphatase (PTP) ß were decreased in the RCCs. We estimated the expression level in the RCCs to be 9 to 18% as compared with a control sample of normal age-adjusted kidney, whereas kidney samples after 6 weeks of repeated Fe-NTA administration showed 69 to 117% (data not shown). Expression of selenoprotein P, intestinal trefoil protein, nicotinamide adenine dinucleotide, reduced form (NADH) dehydrogenase, homologue of human mac25, and homologue of mouse stromal-derived factor 1 (SDF-1) were under the detection limit in the RCCs, whereas they were abundantly expressed in the nontumorous counterparts, as summarized in Table 1 .


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The present study was conducted to find genes that reveal marked alteration in expression during ROS-induced rat renal carcinogenesis, especially in promotion and/or progression stages. We have identified 15 genes (Table 1) and found five novel transcripts (Figure 3) .

Y-box binding protein (YB-1) is a member of DNA-binding protein family with a unique cold shock domain, which is highly conserved from prokaryotes to eukaryotes.18 YB-1 regulates gene expression through binding to Y-box sequence, 5'-CTGATTGG-3', which is contained in the cis-regulatory elements of several genes, including thymidine kinase, cyclin-dependent kinase 1, proliferating cell nuclear antigen (PCNA), DNA polymerase, epidermal growth factor receptor, multidrug resistance 1 (MDR1),19,20 and OxyR, a thiol-containing transcriptional activator21 whose redox status controls the expression of downstream genes.22 YB-1 is an integral component of redox signaling pathway. Recently it was reported that cisplatin resistance was proportionally associated with the expression of YB-1,23 that YB-1 binds preferentially to cisplatin-modified DNA24 and further that increased amounts of nuclear YB-1 was associated with a poor prognosis of ovarian cancer.25 Therefore, it is possible that cells with high expression of YB-1 were selected during carcinogenesis in consideration of the fact that cancer cells, especially adenocarcinoma, are exposed to persistent oxidative stress.26

Ribosomes catalyze protein synthesis with a complex structure including both RNA and protein components. There is increasing evidence that the ribosomal RNA molecules play a central role in its catalytic activities; many of the ribosomal proteins have been relatively poorly conserved, so it has been suggested that the ribosomal proteins mainly enhance the function of the ribosomal RNAs. Overexpression of RP S13 is observed in actively growing cells such as human colorectal carcinoma,27 and overexpression of RP L19 was reported in human breast tumors that overexpress erbB-2.28 There are many reports on the overexpression of other RPs in human cancer: L31 in colorectal tumors,29 P0 in hepatocellular carcinoma and colon carcinoma,30 and L7a and L37 in prostate cancer.31 As far as we know, there are no data available that deal with the association of RP S15 and tumors. Moreover, it was reported that overproduction of mycobacterial RP S13 induces catalase/peroxidase activity, presumably as a stress response which, in this situation, may cause hypersensitivity to isoniazid in Mycobacterium smegmatis.32 Our results support the idea that increased expression of certain ribosomal proteins is associated with oxidative stress and is a common feature of cancer.

Glycoprotein of 96 kd (gp96) and heat shock protein (HSP) 86 belong to the HSP family. Exposure to stress such as heat shock, oxygen deprivation, and calcium or glucose limitation results in the cellular induction of HSPs. These two proteins are involved in stress response, working as a molecular chaperon in the cytoplasm. For example, irradiation and interleukin-6 administration induced gp96 in human cervical and breast cancers, respectively.33,34 These two proteins are coexistent with a broad range of antigen peptides derived from that particular cell and are named as tumor rejection antigen for gp 9635 or tumor-specific transplantation antigen for HSP86,36 and autologous tumor-derived gp96 was used successfully for immunotherapy of tumors.35 HSP86 has been constitutively induced in murine embryonal carcinoma, but is decreased on differentiation,37 suggesting induction of these proteins as a common molecular event in cancers.

Annexin II (also known as calpactin I, p36, or lipocortin II), a Ca2+-binding protein, is a substrate for an oncogene growth factor-associated protein tyrosine kinase. Increased expression of annexin II is observed in pancreatic adenocarcinoma of Syrian hamsters,38 human hepatocellular carcinoma,39 human brain tumor,40 and cell lines of hereditary RCC from Eker rats.41 Recent evidence indicates a role for annexin II in DNA synthesis by interacting with DNA polymerase {alpha},42 cell proliferation,43 and differentiation of F9 teratocarcinoma cells.44 Moreover, it has been reported that expression of annexin II was induced in several sets of transformed cells irrespective of the nature of oncogene products, including v-H-ras-, v-mos-, and SV40-transformed cells.45

Nonmuscle caldesmon, an actin-binding and phosphorylation-activated protein, is closely associated with mitosis; caldesmon stays dissociated from microfilaments from prometaphase until at least the early stages of cytokinesis, suggesting that continued dissociation of caldesmon may be required for mitosis-specific organization of microfilaments, including disassembly of stress fibers and formation and activation of contractile rings for cell division.46 In this context, induction of DNA polymerase catalytic subunit {alpha} and down-regulation of protein-tyrosine phosphatases (PTPases) were consistent in the metabolism of RCCs in the present study.

PTPases regulate tyrosine phosphorylation, which plays a key role in cellular proliferation, differentiation, and oncogenesis.47,48 PTPases can be structurally classified into transmembrane and non-transmembrane isozymes.48 One of the functions of PTPases is to reverse the effect of protein tyrosine kinases, many of which are oncogenes, suggesting that they may act as tumor suppressors.49 Indeed, recently it was reported that expression of PTPase were not observed in 55% of grade 4 glioblastomas, whereas all grade 1 gliomas showed expression50 and were dramatically decreased in lung adenocarcinomas.51 Furthermore, PTPases were found to play a role in cell-to-extracellular matrix communication as well as cell-to-cell communication.52 Our results suggest that decrease in PTPase expression might work for promotion or progression of the initiated cells.

Selenoprotein P is a glycoprotein containing selenocysteine that has been purified from rat and human plasma.53 Selenium is an essential trace element in mammals, and its remarkable biological effect in eukaryotes may be related to a unique function of various selenoproteins such as glutathione peroxidase and thioredoxin reductase.54 Selenoprotein P has been postulated to serve as an extracellular oxidant defense.53 So far there is no report on the association of selenoprotein P and cancer. Deleted expression of selenoproteins in RCCs might lead to more oxidative stress than that of adjacent non-neoplastic tissue, which in turn may contribute to higher oxidative stress and, therefore, genomic instability in cancer.

Trefoil peptides are stable, secreted molecules containing a conserved 6-cysteine motif and are known to be expressed in the gastrointestinal tract and kidney.55 Induction of human spasmolytic polypeptide and porcine spasmolytic polypeptide in the trefoil protein family has been reported in association with peptic ulcers and mucosal injury in inflammatory bowel disease.55 In gastric cell lines, the trefoils were shown to act in a manner suggestive of immediate-early genes capable of auto- and cross-induction through cis-acting regulatory regions: trefoil-mediated transcriptional regulation required activation of the Ras/MEK/MAP kinase signal transduction pathway. Intestinal trefoil factor (ITF) stimulation of gastric cell lines led to phosphorylation of epidermal growth factor receptor.56 Further, it was shown recently that transfection of ITF-3 induced apoptosis in human colon adenocarcinoma cells by perturbing the complexes between E-cadherin, ß-catenin, and associated proteins.57 Although function of this protein in the kidney is still unknown, the same mechanism may work for RCCs. However, we cannot rule out the possibility of "cell population effect," because ITFs were reported to be localized to the collecting ducts of the kidney,58 and the majority of Fe-NTA-induced rat RCCs are thought to arise from proximal tubular epithelial cells.

The mac25 gene is a newly discovered member of the insulin-like growth factor-binding protein (IGFBP) family and renamed as IGFBP-7.59 The IGFBP family regulates the interaction between insulin-like growth factor (IGF)-1 and -2, and their receptors. IGF-1 and -2 play important roles in normal growth and development and have been implicated as growth regulators and potent mitogens in some cancer. It has been reported that decreased expression of mac25/IGFBP-7 during progression of breast carcinomas was associated with allelic loss at human chromosome 4q12–13, where mac25/IGFBP-7 is located.60 This report and our data suggest that this gene may have tumor suppressor or associated function in renal carcinogenesis, and loss of expression may lead to tumor cell growth.

A chemokine, stromal cell-derived factor 1 (SDF-1), is an important regulator of leukocyte and hematopoietic precursor migration and pre-B cell proliferation.61 There are few reports about function and expression of SFD-1 in solid organ and carcinoma. In a recent report, the chemokine receptor CXCR4, which is G-protein-coupled receptor for the CXC chemokine SDF-1, is essential for vascularization of the gastrointestinal tract,62 suggesting SDF-1 and CXCR4 are involved in a new signaling system of organ vascularization. Our results suggest that no expression of SDF-1 mRNA may lead to abnormal angiogenesis in RCCs.

NADH dehydrogenase plays a fundamental role in cellular respiration in both eukaryotes and prokaryotes. This protein is an integral membrane protein whose activity is crucial to the buildup and maintenance of a transmembrane proton gradient, sustained by the reduction of dioxygen to water and by coupling with translocations across the mitochondrial membrane. The genome is present in the mitochondrial DNA. There are reports that expression of NADH dehydrogenase or cytochrome c oxidase is up-regulated in several kinds of cancers.63,64 Our result was the opposite. Of note is the fact that human RCCs show a high incidence of mitochondrial DNA deletion.65 The frequency with which this phenomenon occurs in RCCs, but not in other types of cancers, suggests that this may be an important phenotype associated with renal cell neoplastic transformation. Further study is necessary to elucidate the significance of our results.

The purpose of the present study was to find genes differentially expressed in oxystress-induced cancer based on a hypothesis that either alteration in transcriptional control or genomic deletion may contribute directly to carcinogenesis. We performed a careful selection and identified 15 different clones by screening approximately 84,000 transcripts. It was interesting to find that most of these clones were associated with either stress response or cellular proliferation, but that multiple genetic pathways are apparently involved, as shown in Table 1 . One transcription factor, YB-1, was included. Most of the clones could be classified into "information" and "communication" categories by a proposed genome classification.66 We believe that these transcriptional controls of the identified genes or genomic deletion are working in the promotion and progression processes of carcinogenesis. Further study is now in progress to differentiate between transcriptional shutoff and genomic deletion in the genes with no expression in the RCCs, to find links among the identified genes, and to find earlier changes in combination with morphological approach. Our data also warrant investigation of human cancers for the expression of genes reported in the present study, to test a hypothesis that oxystress-induced cancers share a common panel of gene expression.


    Acknowledgements
 
We thank Ms. Noriko Shibata (Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University) for technical assistance. The sequences reported in this paper have been deposited in the DDBJ/EMBL/GenBank database (Accession: clone 28, AB030380; clone 29, AB030381; clone 256, AB030383; clone 418, AB030383; clone 435, AB030384).


    Footnotes
 
Address reprint requests to Shinya Toyokuni, M.D., Ph.D., Department of Pathology and Biology of Diseases, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan. E-mail: toyokuni{at}path1.med.kyoto-u.ac.jp

Supported in part by a Grant-in-Aid from the Japanese Ministry of Education, Science, Sports and Culture, a grant from the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN), and a grant from the Japanese Owner’s Association.

Accepted for publication February 9, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, 3rd ed. 1999, Clarendon Press, Oxford
  2. Toyokuni S: Oxidative stress and cancer: the role of redox regulation. Biotherapy 1998, 11:147-154[Medline]
  3. Ebina Y, Okada S, Hamazaki, Ogino F, Li J-L, Midorikawa O: Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986, 76:107–113
  4. Li J-L, Okada S, Hamazaki S, Ebina Y, Midorikawa O: Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 1987, 47:1867-1869[Abstract/Free Full Text]
  5. Okada S: Iron-induced tissue damage and cancer: the role of reactive oxygen free radicals. Pathol Int 1996, 46:311-332[Medline]
  6. Toyokuni S: Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996, 20:553-566[Medline]
  7. Toyokuni S, Okada S, Hamazaki S, Minamiyama Y, Yamada Y, Liang P, Fukunaga Y, Midorikawa O: Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res 1990, 50:5574-5580[Abstract/Free Full Text]
  8. Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC: Induction of a wide range of C 2–12 aldehydes and C 7–12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997, 22:1019-1027[Medline]
  9. Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER: Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994, 91:2616-2620[Abstract/Free Full Text]
  10. Uchida K, Fukuda A, Kawakishi S, Hiai H, Toyokuni S: A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch Biochem Biophys 1995, 317:405-411[Medline]
  11. Toyokuni S, Mori T, Dizdaroglu M: DNA base modifications in renal chromatin of Wistar rats, treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 1994, 57:123-128[Medline]
  12. Toyokuni S, Mori T, Hiai H, Dizdaroglu M: Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int J Cancer 1995, 62:309-313[Medline]
  13. Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S: High incidence of allelic loss on chromosome 5 and inactivation of p15 INK4B and p16 INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999, 18:3793-3797[Medline]
  14. Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S: Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 1995, 86:1150-1158[Medline]
  15. Toyokuni S, Tanaka T, Nishiyama Y, Okamoto K, Nakashima Y, Hamazaki S, Okada S, Hiai H: Induction of renal cell carcinoma in male Wistar rats treated with cupric nitrilotriacetate. Lab Invest 1996, 75:239-248[Medline]
  16. Nakanishi H, Takeuchi S, Kato K, Shimizu S, Kobayashi K, Tatematsu M, Shirai T: Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats. Jpn J Cancer Res,87:1218–1226
  17. Tanaka T, Nishiyama Y, Okada K, Hirota K, Matsui M, Yodoi J, Hiai H, Toyokuni S: Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 1997, 77:145-155[Medline]
  18. Wolffe AP, Tafuri S, Ranjan M, Familari M: The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man. New Biol 1992, 4:290-298[Medline]
  19. Ladomery M, Sommerville J: A role for Y-box proteins in cell proliferation. Bioessays 1995, 17:9-11[Medline]
  20. Kohno K, Sato S, Uchiumi T, Takano H, Kato S, Kuwano M: Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J Biol Chem 1990, 265:19690-19696[Abstract/Free Full Text]
  21. Duh JL, Zhu H, Shertzer HG, Nebert DW, Puga: The Y-box motif mediates redox-dependent transcriptional activation in mouse cells. J Biol Chem 1995, 270:30499–30507
  22. Zheng M, Aslund F, Storz G: Activation of the oxyR transcription factor by reversible disulfide bond formation. Science 1998, 279:1718-1721[Abstract/Free Full Text]
  23. Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M, Kuwano M, Kohno K: Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res 1996, 56:4224-4228[Abstract/Free Full Text]
  24. Ise T, Nagatani G, Imamura T, Kato K, Takano H, Nomoto M, Izumi H, Ohmori H, Okamoto T, Ohga T, Uchiumi T, Kuwano M, Kohno K: Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res 1999, 59:342-346[Abstract/Free Full Text]
  25. Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H, Mitsumoto M, Kohno K, Kuwano M, Nakano H: Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 1999, 85:2450–2454,
  26. Toyokuni S, Okamoto K, Yodoi J, Hiai H: Hypothesis: persistent oxidative stress in cancer. FEBS Lett 1995, 358:1-3[Medline]
  27. Denis MG, Chadeneau C, Lecabellec MT, LeMoullac B, LeMevel B, Meflah K, Lustenberger P: Over-expression of the S13 ribosomal protein in actively growing cells. Int J Cancer 1993, 55:275-280[Medline]
  28. Henry JL, Coggin DL, King CR: High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 1993, 53:1403-1408[Abstract/Free Full Text]
  29. Chester KA, Robson L, Begent RHJ, Talbot IC, Pringle JH, Primrose L, Macpherson AJS, Boxer G, Southall P, Malcolm ADB: Identification of a human ribosomal protein mRNA with increased expression in colorectal tumours. Biochim Biophys Acta 1989, 1009:297-300[Medline]
  30. Barnard GF, Staniunas RJ, Bao S, Mafune K, Steele GDJ, Gollan JL, Chen LB: Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocelllular carcinoma and colon carcinoma. Cancer Res 1992, 52:3067-3072[Abstract/Free Full Text]
  31. Vaarala MH, Porvari KS, Kylloenen AP, Mustonen MVJ, Lukkarinen O, Vihko PT: Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples. Int J Cancer 1998, 78:27-32[Medline]
  32. Dubnau E, Soares S, Huang TJ, Jacobs WRJ: Overproduction of mycobacterial ribosomal protein S13 induces catalase/peroxidase activity and hypersensitivity to isoniazid in Mycobacterium smegmatis. Gene 1996, 170:17-22[Medline]
  33. Santin AD, Hermonat PL, Ravaggi A, Chiriva-Internati M, Hiserodt JC, Batchu RB, Pecorelli S, Parham GP: The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer. Int J Radiat Biol 1998, 73:699-704[Medline]
  34. Haverty AA, Harmey JH, Redmond HP, Bouchier-Hayes DJ: Interleukin-6 upregulates GP96 expression in breast cancer. J Surg Res 1997, 69:145-149[Medline]
  35. Maki RG, Old LJ, Srivastava PK: Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relatonships to stress-induced proteins. Proc Natl Acad Sci USA 1990, 87:5658-5662[Abstract/Free Full Text]
  36. Hoffmann T, Hovemann B: Heat-shock proteins, Hsp84 and Hsp86, of mice and men: two related genes encode formerly identified tumour-specific transplantation antigens. Gene 1998, 74:491-501
  37. Legagneux V, Mezger V, Quelard C, Barnier JV, Bensaude O, Morange M: High constitutive transcription of HSP86 gene in murine embryonal carcinoma cells. Differentiation 1989, 41:42-48[Medline]
  38. Kumble KD, Hirota M, Pour PM, Vishwanatha JK: Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. Cancer Res 1999, 52:163-167[Abstract/Free Full Text]
  39. Frohrich M, Motte P, Galvin K, Takahashi H, Wands J, Ozturk M: Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. Mol Cell Biol 1990, 10:3216-3223[Abstract/Free Full Text]
  40. Reeves SA, Chavez-Kappel C, Davis R, Rosenblum M, Israel MA: Developmental regulation of annexin II (lipocortin 2) in human brain and expression in high grade glioma. Cancer Res 1992, 52:6871-6876[Abstract/Free Full Text]
  41. Hino O, Kobayashi E, Nishizawa M, Kubo Y, Kobayashi T, Hirayama Y, Takai S, Kikuchi Y, Tsuchiya H, Orimoto K: Renal carcinogenesis in the Eker rat. J Cancer Res Clin Oncol, 121:602–605
  42. Jindal HK, Chaney WG, Anderson CW, Davis RG, Vishwanatha JK: The protein-tyrosine kinase substrate calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase {alpha}. J Biol Chem 1991, 266:5169-5176[Abstract/Free Full Text]
  43. Kumble KD, Iversen PL, Vishwanatha JK: The role of primer recognition proteins in DNA repllication: inhibition of cellular proliferation by antisense oligodeoxyribonucleotides. J Cell Sci 1992, 101:35-41[Abstract/Free Full Text]
  44. Harder T, Thiel C, Gerke V: Formation of the annexin II2p11(2) complex upon differentiation of F9 teratocarcinoma cells. J Cell Sci 1993, 104:1109-1117[Abstract]
  45. Ozaki T, Sakiyama S: Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines. Oncogene 1993, 8:1707-1710[Medline]
  46. Hosoya N, Hosoya H, Yamashiro S, Mohri H, Matsumura F: Localization of caldesmon and its dephosphorylation during cell division. J Cell Biol 1993, 121:1075-1082[Abstract/Free Full Text]
  47. Hunter T: Protein-tyrosine phosphatases: the other side of the coin. Cell 1989, 58:1013-1016[Medline]
  48. Fischer EH, Charbonneau H, Tonks NK: Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 1991, 253:401-406[Abstract/Free Full Text]
  49. LaForgia S, Morse B, Levy J, Barnea G, Cannizzaro LA, Li F, Nowell PC, Boghosian-Sell L, Glick J, Weston A, Harris CC, Drabkin H, Patterson D, Croce CM, Schlessinger J, Huebner K: Receptor protein-tyrosine phosphatase {gamma} is a candidate tumor suppressor gene at human chromosome region 3p21. Proc Natl Acad Sci USA 1991, 88:5036-5040[Abstract/Free Full Text]
  50. Norman SA, Golfinos JG, Scheck AC: Expression of a receptor protein tyrosine phosphatase in human glial tumors. J Neurooncol 1998, 36:209-217[Medline]
  51. Gaits F, Li RY, Ragab A, Selves J, Ragab-Thomas JM, Chap H: Implication of a protein-tyrosine-phosphatase in human lung cancer. Cell Mol Biol 1994, 40:677-685
  52. Peles E, Schlessinger J, Grumet M: Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling. Trends Biochem Sci 1998, 23:121-124[Medline]
  53. Burk RF, Hill KE: Selenoprotein P: a selenium-rich extracellular glycoprotein. J Nutr 1994, 124:1891-1897
  54. van Vleet JF, Ferrans VJ: Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans. Biol Trace Element Res 1992, 33:1-21
  55. Suemori S, Lynch-Devaney K, Podolsky DK: Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991, 88:11017-11021[Abstract/Free Full Text]
  56. Taupin D, Wu DC, Jeon WK, Devaney K, Wang TC, Podolsky DK: The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest 1999, 103:R31-R38[Medline]
  57. Efstathiou JA, Noda M, Rowan A, Dixon C, Chinery R, Jawhari A, Hattori T, Wright NA, Bodmer WF, Pignatelli M: Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci USA, 95:3122–3127
  58. Chinery R, Poulsom R, Elia G, Hanby AM, Wright NA: Expression and purification of a trefoil peptide motif in a ß-galactosidase fusion protein and its use to search for trefoil-binding sites. Eur J Biochem 1993, 212:557-563[Medline]
  59. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG: Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. J Biol Chem 1996, 48:30322-30325
  60. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, Papas T, Seth A: Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with desease progression in breast carcinomas. Oncogene 1998, 16:2459-2467[Medline]
  61. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453[Abstract/Free Full Text]
  62. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T: The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-594[Medline]
  63. Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB: Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 1996, 56:3634-3637[Abstract/Free Full Text]
  64. Starkey CR, Levy LS: Identification of differentially expressed genes in T-lymphoid malignancies in an animal model system. Int J Cancer 1995, 62:325-331[Medline]
  65. Selvanayagam P, Rajaraman S: Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma. Lab Invest 1996, 74:592-599[Medline]
  66. Tamames J, Ouzounis C, Sander C, Valencia A: Genomes with distinct function composition. FEBS Lett 1999, 389:96-101



This article has been cited by other articles:


Home page
Toxicol SciHome page
Q. Yang, T. Nagano, Y. Shah, C. Cheung, S. Ito, and F. J. Gonzalez
The PPAR{alpha}-Humanized Mouse: A Model to Investigate Species Differences in Liver Toxicity Mediated by PPAR{alpha}
Toxicol. Sci., January 1, 2008; 101(1): 132 - 139.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. Yang, D. J. Weber, and F. Carrier
Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18
Nucleic Acids Res., March 2, 2006; 34(4): 1224 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
A. Luhe, H. Hildebrand, U. Bach, T. Dingermann, and H.-J. Ahr
A New Approach to Studying Ochratoxin A (OTA)-Induced Nephrotoxicity: Expression Profiling in Vivo and in Vitro Employing cDNA Microarrays
Toxicol. Sci., June 1, 2003; 73(2): 315 - 328.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. S. Coles, P. Diamond, L. Lambrusco, J. Hunter, J. Burrows, M. A. Vadas, and G. J. Goodall
A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts
Nucleic Acids Res., November 15, 2002; 30(22): 4845 - 4854.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
V. Gerke and S. E. Moss
Annexins: From Structure to Function
Physiol Rev, April 1, 2002; 82(2): 331 - 371.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yang and F. Carrier
The UV-inducible RNA-binding Protein A18 (A18 hnRNP) Plays a Protective Role in the Genotoxic Stress Response
J. Biol. Chem., December 7, 2001; 276(50): 47277 - 47284.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. N. Young, M. B. Amin, C. S. Moreno, S. D. Lim, C. Cohen, J. A. Petros, F. F. Marshall, and A. S. Neish
Expression Profiling of Renal Epithelial Neoplasms : A Method for Tumor Classification and Discovery of Diagnostic Molecular Markers
Am. J. Pathol., May 1, 2001; 158(5): 1639 - 1651.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Toyokuni, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Toyokuni, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS